KILEY WALKER: Open Payments
NPI 1902475049 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 20 payments from 8 companies in 2025. Trend: 2023 $33 · 2024 $424 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $184 |
| PFIZER INC. | 3 | $73 |
| ABBVIE INC. | 3 | $53 |
| GENZYME CORPORATION | 2 | $45 |
| Lilly USA, LLC | 2 | $44 |
| Amgen Inc. | 1 | $25 |
| Organogenesis Inc. | 1 | $16 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
Products named: CIBINQO, COSENTYX, Rhapsido, SKYRIZI, DUPIXENT, EBGLYSS, OTEZLA, CYGNUS DUAL.
Industry payments across IN — which companies pay providers there.
